🔎 Trials Near Me

Pradžia › Nutukimas › Minesota › Minneapolis

Nutukimas klinikiniai tyrimai Minneapolis, MN

13 tyrimai dėl Nutukimas ieško dalyvių vietose Minneapolis ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Renkami dalyviai3 fazė
  • International Diabetes Center, Minneapolis
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07533175

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

Renkami dalyviai3 fazė
  • International Diabetes Center, Minneapolis
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07564414

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Renkami dalyviai3 fazė
  • University of Minnesota, Minneapolis
Amžius nuo 8 iki 18 · Visoms lytims · Atnaujinta 2026-09-30 · NCT07253285

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Renkami dalyviai3 fazė
  • University of Minnesota Masonic Children's Hospital, Minneapolis
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06672549

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Renkami dalyviai3 fazė
  • Minneapolis Heart Institute Foundation, Minneapolis
Amžius nuo 45 iki 99 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07037433

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Renkami dalyviai3 fazė
  • University of Minnesota, Minneapolis
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-09-16 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Renkami dalyviai3 fazė
  • International Diabetes Center At Park Nicollet, Minneapolis
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-14 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Renkami dalyviai3 fazėLaukiami sveiki savanoriai
  • ACCOMPLISH-2 Research Site, Minneapolis
Amžius nuo 18 iki 79 · Visoms lytims · Atnaujinta 2026-09-11 · NCT07654374

tDCS With Cognitive Training to Reduce Impulsivity and Weight in Veterans With Obesity

Renkami dalyviai
  • Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-08 · NCT05225233

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Renkami dalyviai2 fazė
  • Children's Hospitals and Clinics of Minnesota, Minneapolis
Amžius nuo 7 iki 25 · Visoms lytims · Atnaujinta 2026-08-19 · NCT05082519

A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity

Renkami dalyviai4 fazė
  • Clinical Research Institute of Minnesota, Minneapolis
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-07-27 · NCT07728383

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

Renkami dalyviai
  • Minneapolis VA Health Care System, Minneapolis
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-22 · NCT06390345

Project SHINE (Sleep Health INitiative for Equity): Culturally Informing a Sleep Extension Intervention for African American Adults

Renkami dalyviai1/2 fazė
  • University of Minnesota, Minneapolis
Amžius nuo 21 iki 75 · Visoms lytims · Atnaujinta 2025-12-17 · NCT06226077

Nutukimas tyrimai kituose miestuose

Kiti tyrimai Minneapolis

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.